Pozzi A - Search Results

1

Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy.

Boiardi A, Silvani A, Pozzi A, Farinotti M, Fariselli L, Broggi G, Salmaggi A. Boiardi A, et al. Among authors: pozzi a. J Neurooncol. 1997 Sep;34(2):179-85. doi: 10.1023/a:1005705624858. J Neurooncol. 1997. PMID: 9210066

2

Chemotherapy is effective as early treatment for primary central nervous system lymphoma.

Boiardi A, Silvani A, Pozzi A, Fariselli L, Broggi G, Salmaggi A. Boiardi A, et al. Among authors: pozzi a. J Neurol. 1999 Jan;246(1):31-7. doi: 10.1007/s004150050302. J Neurol. 1999. PMID: 9987711

3

Interstitial chemotherapy plus systemic chemotherapy for glioblastoma patients: improved survival in sequential studies.

Boiardi A, Silvani A, Pozzi A, Fariselli L, Broggi G, Salmaggi A. Boiardi A, et al. Among authors: pozzi a. J Neurooncol. 1999 Jan;41(2):151-7. doi: 10.1023/a:1006119505170. J Neurooncol. 1999. PMID: 10222435 Clinical Trial.

4

Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients.

Boiardi A, Eoli M, Pozzi A, Salmaggi A, Broggi G, Silvani A. Boiardi A, et al. Among authors: pozzi a. Ital J Neurol Sci. 1999 Feb;20(1):43-8. doi: 10.1007/s100720050009. Ital J Neurol Sci. 1999. PMID: 10933484

5

Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: preliminary data.

Boiardi A, Salmaggi A, Pozzi A, Broggi G, Silvani A. Boiardi A, et al. Among authors: pozzi a. J Neurooncol. 1996 Feb;27(2):157-62. doi: 10.1007/BF00177479. J Neurooncol. 1996. PMID: 8699238

6

Effectiveness of early chemotherapy treatment in anaplastic astrocytoma patients.

Silvani A, Salmaggi A, Pozzi A, Fariselli L, Franzini A, Boiardi A. Silvani A, et al. Among authors: pozzi a. Tumori. 1995 Nov-Dec;81(6):424-8. doi: 10.1177/030089169508100607. Tumori. 1995. PMID: 8804468

7

Safety and potential effectiveness of daunorubicin-containing liposomes in patients with advanced recurrent malignant CNS tumors.

Boiardi A, Pozzi A, Salmaggi A, Eoli M, Zucchetti M, Silvani A. Boiardi A, et al. Among authors: pozzi a. Cancer Chemother Pharmacol. 1999;43(2):178-9. doi: 10.1007/s002800050881. Cancer Chemother Pharmacol. 1999. PMID: 9923826 Clinical Trial. No abstract available.

8

Antineuronal antibodies in patients with neuroblastoma: relationships with clinical features.

Salmaggi A, Luksch R, Forno MG, Pozzi A, Silvani A, Boiardi A, Gasparini M, Nemni R. Salmaggi A, et al. Among authors: pozzi a. Tumori. 1997 Nov-Dec;83(6):953-7. doi: 10.1177/030089169708300616. Tumori. 1997. PMID: 9526591

9

Radiotherapy at tumor recurrence in primary CNS lymphoma.

Boiardi A, Silvani A, Pozzi A, Salmaggi A. Boiardi A, et al. Among authors: pozzi a. Neurology. 1998 Jun;50(6):1934-5. doi: 10.1212/wnl.50.6.1934-b. Neurology. 1998. PMID: 9633783 Clinical Trial. No abstract available.

10

Tumor necrosis factor microsatellite polymorphisms in Italian glioblastoma patients.

Frigerio S, Ciusani E, Pozzi A, Silvani A, Salmaggi A, Boiardi A. Frigerio S, et al. Among authors: pozzi a. Cancer Genet Cytogenet. 1999 Mar;109(2):172-4. doi: 10.1016/s0165-4608(98)00161-7. Cancer Genet Cytogenet. 1999. PMID: 10087955

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

618 results

Search Page

Filters